Skip to main content

24-09-2020 | ESMO 2020 | Conference coverage | Video

BIONIKK demonstrates feasibility of gene signature-guided RCC treatment selection

Yann-Alexandre Vano provides an overview of the biomarker-driven BIONIKK trial in metastatic renal cell carcinoma, and outlines the research needed to implement the findings clinically (4:02).

Read transcript